Marc L. Berger, MD
Consultant and Scientific Advisor

Marc L. Berger, MD, is a semi-retired, part-time consultant and scientific advisor.  Until July 2017, he was Vice President, Real World Data and Analytics (RWDnA) at Pfizer, Inc. Marc has held senior-level positions in industry including Executive Vice President and Senior Scientist at OptumInsight; Vice President, Global Health Outcomes at Eli Lilly and Company; and Vice President, Outcomes Research and Management at Merck & Co., Inc. 

He currently serves as advisor to a number of pharmaceutical and health data analytics companies. Additionally, Marc is a Special Advisor for Real World Evidence to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) contributing to its ongoing efforts and that of other organizations such as the Duke-Margolis Center for Health Policy to promote best practices in the creation of real-world evidence (RWE). Marc has written or co-written more than 130 peer-reviewed articles, book chapters, and other publications on a range of topics including health services research, outcomes research, health economics, and health policy. He received the Donabedian Lifetime Achievement Award from ISPOR in 2019.